Bank of New York Mellon’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $9K | Sell |
|
|||||
|
2022
Q1 | $50K | Hold |
|
|||||
|
2021
Q4 | $52K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $161K | Hold |
|
|||||
|
2020
Q4 | $181K | Hold |
|
|||||
|
2020
Q3 | $228K | Sell |
|
|||||
|
2020
Q2 | $293K | Buy |
|
|||||
|
2020
Q1 | $154K | Hold |
|
|||||
|
2019
Q4 | $206K | Buy |
|
|||||
|
2019
Q3 | $120K | Hold |
|
|||||
|
2019
Q2 | $111K | Hold |
|
|||||
|
2019
Q1 | $141K | Buy |
|
|||||
|
2018
Q4 | $67K | Hold |
|
|||||
|
2018
Q3 | $106K | Hold |
|
|||||
|
2018
Q2 | $102K | Hold |
|
|||||
|
2018
Q1 | $62K | Hold |
|
|||||
|
2017
Q4 | $62K | Hold |
|
|||||
|
2017
Q3 | $130K | Hold |
|
|||||
|
2017
Q2 | $103K | Buy |
|
|||||
|
2017
Q1 | $101K | Buy |
|